OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Association Between Use of Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors and Cognitive Function in a Longitudinal Study of Patients with Type 2 Diabetes
Serena Low, Kiat Sern Goh, Tze Pin Ng, et al.
Journal of Alzheimer s Disease (2022) Vol. 87, Iss. 2, pp. 635-642
Closed Access | Times Cited: 32
Serena Low, Kiat Sern Goh, Tze Pin Ng, et al.
Journal of Alzheimer s Disease (2022) Vol. 87, Iss. 2, pp. 635-642
Closed Access | Times Cited: 32
Showing 1-25 of 32 citing articles:
Association of Sodium–Glucose Cotransporter 2 Inhibitors With Time to Dementia: A Population-Based Cohort Study
Che‐Yuan Wu, Carina Iskander, Christa Wang, et al.
Diabetes Care (2022) Vol. 46, Iss. 2, pp. 297-304
Open Access | Times Cited: 71
Che‐Yuan Wu, Carina Iskander, Christa Wang, et al.
Diabetes Care (2022) Vol. 46, Iss. 2, pp. 297-304
Open Access | Times Cited: 71
Sodium-glucose cotransporter-2 inhibitors and their potential role in dementia onset and cognitive function in patients with diabetes mellitus: a systematic review and meta-analysis
Y J Youn, Seung Yeon Kim, Hyun‐Jeong Jeong, et al.
Frontiers in Neuroendocrinology (2024) Vol. 73, pp. 101131-101131
Open Access | Times Cited: 20
Y J Youn, Seung Yeon Kim, Hyun‐Jeong Jeong, et al.
Frontiers in Neuroendocrinology (2024) Vol. 73, pp. 101131-101131
Open Access | Times Cited: 20
Impact of Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i) Therapy on Dementia and Cognitive Decline
Antonio Lardaro, L. Quarta, Stefania Pagnotta, et al.
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1750-1750
Open Access | Times Cited: 15
Antonio Lardaro, L. Quarta, Stefania Pagnotta, et al.
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1750-1750
Open Access | Times Cited: 15
Type 2 diabetes mellitus and cognitive function: understanding the connections
Lisa Dao, Sarah Choi, Matthew Freeby
Current Opinion in Endocrinology Diabetes and Obesity (2022) Vol. 30, Iss. 1, pp. 7-13
Closed Access | Times Cited: 43
Lisa Dao, Sarah Choi, Matthew Freeby
Current Opinion in Endocrinology Diabetes and Obesity (2022) Vol. 30, Iss. 1, pp. 7-13
Closed Access | Times Cited: 43
Pharmacological Approaches Using Diabetic Drugs Repurposed for Alzheimer’s Disease
Muna A. Adem, Boris Decourt, Marwan N. Sabbagh
Biomedicines (2024) Vol. 12, Iss. 1, pp. 99-99
Open Access | Times Cited: 15
Muna A. Adem, Boris Decourt, Marwan N. Sabbagh
Biomedicines (2024) Vol. 12, Iss. 1, pp. 99-99
Open Access | Times Cited: 15
SGLT2 inhibitors: a novel therapy for cognitive impairment via multifaceted effects on the nervous system
Jiaqi Mei, Yi Li, Liyan Niu, et al.
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 13
Jiaqi Mei, Yi Li, Liyan Niu, et al.
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 13
Risk of dementia after initiation of sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in adults aged 40-69 years with type 2 diabetes: population based cohort study
Anna Shin, Bo Kyung Koo, Jun Young Lee, et al.
BMJ (2024), pp. e079475-e079475
Open Access | Times Cited: 12
Anna Shin, Bo Kyung Koo, Jun Young Lee, et al.
BMJ (2024), pp. e079475-e079475
Open Access | Times Cited: 12
Assessment of sodium-glucose cotransporter 2 inhibitors (SGLT2i) and other antidiabetic agents in Alzheimer’s disease: A population-based study
Mar Garcia-Zamora, Gemma García‐Lluch, Lucrecia Moreno, et al.
Pharmacological Research (2024) Vol. 206, pp. 107295-107295
Open Access | Times Cited: 11
Mar Garcia-Zamora, Gemma García‐Lluch, Lucrecia Moreno, et al.
Pharmacological Research (2024) Vol. 206, pp. 107295-107295
Open Access | Times Cited: 11
The impact of sodium‐glucose co‐transporter‐2 inhibitors on dementia and cardiovascular events in diabetic patients with atrial fibrillation
Yun‐Yu Chen, Hao‐Chih Chang, Yenn‐Jiang Lin, et al.
Diabetes/Metabolism Research and Reviews (2024) Vol. 40, Iss. 2
Open Access | Times Cited: 10
Yun‐Yu Chen, Hao‐Chih Chang, Yenn‐Jiang Lin, et al.
Diabetes/Metabolism Research and Reviews (2024) Vol. 40, Iss. 2
Open Access | Times Cited: 10
The effect of sodium glucose Co-transport 2 inhibitors on cognitive impairment and depression in type 2 diabetes mellitus patients
Ashurova Nodirahon, Haya Majid, Swati Waghdhare, et al.
Clinical Epidemiology and Global Health (2024) Vol. 26, pp. 101555-101555
Open Access | Times Cited: 10
Ashurova Nodirahon, Haya Majid, Swati Waghdhare, et al.
Clinical Epidemiology and Global Health (2024) Vol. 26, pp. 101555-101555
Open Access | Times Cited: 10
Repurposing antidiabetic drugs for Alzheimer's disease: A review of preclinical and clinical evidence and overcoming challenges
Jacky Tran, Sneh Parekh, Julia Rockcole, et al.
Life Sciences (2024) Vol. 355, pp. 123001-123001
Closed Access | Times Cited: 8
Jacky Tran, Sneh Parekh, Julia Rockcole, et al.
Life Sciences (2024) Vol. 355, pp. 123001-123001
Closed Access | Times Cited: 8
SGLT2i and Cardiovascular Events in Patients With Concomitant Atrial Fibrillation and Diabetes: A TriNetX Cohort Study
Yu–Yu Hsiao, Yun‐Yu Chen, Ming‐Jen Kuo, et al.
The Journal of Clinical Endocrinology & Metabolism (2025)
Open Access | Times Cited: 1
Yu–Yu Hsiao, Yun‐Yu Chen, Ming‐Jen Kuo, et al.
The Journal of Clinical Endocrinology & Metabolism (2025)
Open Access | Times Cited: 1
Efficacy and safety profile of SGLT2 inhibitors in the elderly: How is the benefit/risk balance?
André Scheen, Fabrice Bonnet
Diabetes & Metabolism (2023) Vol. 49, Iss. 2, pp. 101419-101419
Open Access | Times Cited: 20
André Scheen, Fabrice Bonnet
Diabetes & Metabolism (2023) Vol. 49, Iss. 2, pp. 101419-101419
Open Access | Times Cited: 20
Diabetes-Alzheimer's connection in older age: SGLT2 inhibitors as promising modulators of disease pathways
Francesca Mancinetti, Dionysios P. Xenos, Michelantonio De Fano, et al.
Ageing Research Reviews (2023) Vol. 90, pp. 102018-102018
Closed Access | Times Cited: 20
Francesca Mancinetti, Dionysios P. Xenos, Michelantonio De Fano, et al.
Ageing Research Reviews (2023) Vol. 90, pp. 102018-102018
Closed Access | Times Cited: 20
Mitochondria and the Repurposing of Diabetes Drugs for Off-Label Health Benefits
Joyce Yip, Grace Shu Hui Chiang, I Lee, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 1, pp. 364-364
Open Access
Joyce Yip, Grace Shu Hui Chiang, I Lee, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 1, pp. 364-364
Open Access
Comparative Effectiveness of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Preventing Alzheimer's Disease, Vascular Dementia, and Other Dementia Types Among Patients with Type 2 Diabetes
Mingyang Sun, Xiaoling Wang, Zhongyuan Lu, et al.
Diabetes & Metabolism (2025), pp. 101623-101623
Closed Access
Mingyang Sun, Xiaoling Wang, Zhongyuan Lu, et al.
Diabetes & Metabolism (2025), pp. 101623-101623
Closed Access
Unveiling the mTOR pathway modulation by SGLT2 inhibitors: a novel approach to Alzheimer’s disease in type 2 diabetes
Prakash Ramakrishan, Jayaraman Rajangam, Shaheedha Shabudeen Mahinoor, et al.
Metabolic Brain Disease (2025) Vol. 40, Iss. 3
Closed Access
Prakash Ramakrishan, Jayaraman Rajangam, Shaheedha Shabudeen Mahinoor, et al.
Metabolic Brain Disease (2025) Vol. 40, Iss. 3
Closed Access
Association of sodium‐glucose cotransporter 2 inhibitors with risk of incident dementia and all‐cause mortality in older patients with type 2 diabetes: A retrospective cohort study using the TriNetX US collaborative networks
Yen‐Wei Pai, I‐Chieh Chen, Jun‐Fu Lin, et al.
Diabetes Obesity and Metabolism (2024)
Closed Access | Times Cited: 4
Yen‐Wei Pai, I‐Chieh Chen, Jun‐Fu Lin, et al.
Diabetes Obesity and Metabolism (2024)
Closed Access | Times Cited: 4
SGLT2 inhibition, circulating biomarkers, and Alzheimer's disease: A Mendelian randomization study
Hao Yang, Yuye Ning, Meiling Chen, et al.
Journal of Alzheimer s Disease (2025)
Closed Access
Hao Yang, Yuye Ning, Meiling Chen, et al.
Journal of Alzheimer s Disease (2025)
Closed Access
Association between use of sodium-glucose co-transporter-2 inhibitor and the risk of incident dementia: a population-based cohort study
Zarin Abdullah, Ying Cui, Robert W. Platt, et al.
BMJ Open Diabetes Research & Care (2025) Vol. 13, Iss. 1, pp. e004541-e004541
Open Access
Zarin Abdullah, Ying Cui, Robert W. Platt, et al.
BMJ Open Diabetes Research & Care (2025) Vol. 13, Iss. 1, pp. e004541-e004541
Open Access
Use of sodium‐glucose cotransporter‐2 inhibitors and risk of dementia: A population‐based cohort study
Lin Zhuo, Baixue Zhang, Yueqi Yin, et al.
Diabetes Obesity and Metabolism (2025)
Closed Access
Lin Zhuo, Baixue Zhang, Yueqi Yin, et al.
Diabetes Obesity and Metabolism (2025)
Closed Access
Krill oil attenuates diabetes-associated cognitive dysfunction by inhibiting microglial polarization-induced neuron injury
Ao Tian, Lei Sun, Zheng Yan, et al.
Journal of Functional Foods (2024) Vol. 114, pp. 106064-106064
Open Access | Times Cited: 3
Ao Tian, Lei Sun, Zheng Yan, et al.
Journal of Functional Foods (2024) Vol. 114, pp. 106064-106064
Open Access | Times Cited: 3
Association between diabetes mellitus and post‐stroke cognitive impairment
Kang‐Po Lee, Jung‐Sheng Chen, Chih‐Yuan Wang
Journal of Diabetes Investigation (2022) Vol. 14, Iss. 1, pp. 6-11
Open Access | Times Cited: 15
Kang‐Po Lee, Jung‐Sheng Chen, Chih‐Yuan Wang
Journal of Diabetes Investigation (2022) Vol. 14, Iss. 1, pp. 6-11
Open Access | Times Cited: 15
Clinical antidiabetic medication used in Alzheimer’s disease: From basic discovery to therapeutics development
Juan Huang, Nanqu Huang, Di Cui, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 7
Juan Huang, Nanqu Huang, Di Cui, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 7
Cognitive impairment in heart failure patients: association with abnormal circadian blood pressure rhythm: a review from the HOPE Asia Network
Takahiro Komori, Satoshi Hoshide, Yuda Turana, et al.
Hypertension Research (2023)
Closed Access | Times Cited: 6
Takahiro Komori, Satoshi Hoshide, Yuda Turana, et al.
Hypertension Research (2023)
Closed Access | Times Cited: 6
